Skip to content

Clinical trials

Phase 3 Acquired Immunodeficiency Syndrome trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acquired Immunodeficiency Syndrome Phase: Phase 3 Country / region: United Kingdom Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20073
20082
20101
20115
20122
20132
20152
20162
20181
20191
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare12
Gilead Sciences5
Tibotec Pharmaceuticals, Ireland4
Janssen R&D Ireland2
Janssen-Cilag International NV2
Chelsea and Westminster NHS Foundation Trust1
Janssen Sciences Ireland UC1
NEAT ID Foundation1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acquired Immunodeficiency Syndrome29
HIV Infections16
Infections7
Cytomegalovirus Infections1
Hepatitis C, Chronic1
Virus Diseases1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.